Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

Total article views   HTML views PDF downloads Totals
19,340 Dovepress* 11,674+ 1,471 13,145
PubMed Central* 7,666 943 8,609
Totals 19,340 2,414 21,754
*Since 5 March 2021
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar